Company: BIVIW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001520138-25-000247
Chunk: 125

Company: BIOVIE INC.
Filing Date: 2025-08-08
Form: 424B5
Chunk 125
---
-------|:----|:--------------------------------------------------------------------------------------------|-------:|:----|:----------------------------------------------------------------------------|-------:|:----|:-------------------------------------------------------------------------------------------------------------------------------------------|-------:|
| Equity compensation plans approved by security holders |     |                                                                                             | 92,028 |     | $                                                                           | 271.06 |     |                                                                                                                                            | 65,682 |
| Equity compensation not approved by security holders   |     |                                                                                             |      — |     | $                                                                           |      — |     |                                                                                                                                            |      — |
| Total                                                  |     |                                                                                             | 92,028 |     | $                                                                           | 271.06 |     |                                                                                                                                            | 65,682 |

<div align='center'>69

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</div>

There have been no transactions since July 1, 2024 to which we have
been a party in which the amount involved exceeded or will exceed the lesser of (i) $120,000 and (ii) one percent (1%) of the average
of our total assets at year-end for the prior two fiscal years, and in which any of our directors, executive officers or beneficial owners
of more than 5% of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or
indirect material interest.

Review and Approval of Transactions with Related Persons

Either the audit committee or the Board of Directors approves all related
party transactions. The procedure for the review, approval or ratification of related party transactions involves discussing the proposed
transaction with management, discussing the proposed transaction with the external auditors, reviewing financial statements and related
disclosures, and reviewing the details of major deals and transactions to ensure that they do not involve related party transactions.
Members of management have been informed and understand that they are to bring related party transactions to the audit committee or the
Board of Directors for pre-approval. These policies and procedures are evidenced in the audit committee charter and our code of ethics.

<div align='center'>70

Principal Stockholders</div>

Based solely upon information made available to us, the following table
sets forth information as of June 30, 2025 regarding the beneficial ownership of our Common Stock by:

| · | each person known by us to be the beneficial owner of more than 5% of our outstanding shares of Common 
 Stock;                                                                                                 |

| · | each of our named executive officers and directors; and |

| · | all our executive